المؤلفون: Qiuping Chen, Quan Sun, Jing Zhang, Baixue Li, Quansheng Feng, Jibin Liu

مصطلحات موضوعية: Medicine, Ecology, Cancer, Science Policy, Biological Sciences not elsewhere classified, main factors affecting, economic advantage grew, current economic conditions, brought health benefits, access database (<, way sensitivity analysis, probabilistic sensitivity analysis, within 1000 times, unresectable hepatocellular carcinoma, patients ’ lifetime, monte carlo simulation, sorafenib therapeutic scheme, tislelizumab vs sorafenib, tislelizumab therapeutic scheme, wtp &# 8805, tislelizumab group generated, tislelizumab group became, psa results showed, pd ), cost, oswa results showed, effectiveness acceptability curves, china ($ 37653, sorafenib group, tislelizumab group

Relation: https://figshare.com/articles/figure/Results_of_the_survival_curve_fit_the_Tislelizumab_of_the_base-case_analysis_in_the_partitioned_survival_model_/25336828

الاتاحة: https://doi.org/10.1371/journal.pone.0295090.g001
https://figshare.com/articles/figure/Results_of_the_survival_curve_fit_the_Tislelizumab_of_the_base-case_analysis_in_the_partitioned_survival_model_/25336828

المؤلفون: Qiuping Chen, Quan Sun, Jing Zhang, Baixue Li, Quansheng Feng, Jibin Liu

مصطلحات موضوعية: Medicine, Ecology, Cancer, Science Policy, Biological Sciences not elsewhere classified, main factors affecting, economic advantage grew, current economic conditions, brought health benefits, access database (<, way sensitivity analysis, probabilistic sensitivity analysis, within 1000 times, unresectable hepatocellular carcinoma, patients ’ lifetime, monte carlo simulation, sorafenib therapeutic scheme, tislelizumab vs sorafenib, tislelizumab therapeutic scheme, wtp &# 8805, tislelizumab group generated, tislelizumab group became, psa results showed, pd ), cost, oswa results showed, effectiveness acceptability curves, china ($ 37653, sorafenib group, tislelizumab group

Relation: https://figshare.com/articles/figure/The_one-way_sensitivity_analysis_results_presented_by_tornado_diagram_/25336834

الاتاحة: https://doi.org/10.1371/journal.pone.0295090.g003
https://figshare.com/articles/figure/The_one-way_sensitivity_analysis_results_presented_by_tornado_diagram_/25336834

المؤلفون: Qiuping Chen, Quan Sun, Jing Zhang, Baixue Li, Quansheng Feng, Jibin Liu

مصطلحات موضوعية: Medicine, Ecology, Cancer, Science Policy, Biological Sciences not elsewhere classified, main factors affecting, economic advantage grew, current economic conditions, brought health benefits, access database (<, way sensitivity analysis, probabilistic sensitivity analysis, within 1000 times, unresectable hepatocellular carcinoma, patients ’ lifetime, monte carlo simulation, sorafenib therapeutic scheme, tislelizumab vs sorafenib, tislelizumab therapeutic scheme, wtp &# 8805, tislelizumab group generated, tislelizumab group became, psa results showed, pd ), cost, oswa results showed, effectiveness acceptability curves, china ($ 37653, sorafenib group, tislelizumab group

Relation: https://figshare.com/articles/figure/Results_of_the_survival_curve_fit_the_Sorafenib_of_the_base-case_analysis_in_the_partitioned_survival_model_/25336831

الاتاحة: https://doi.org/10.1371/journal.pone.0295090.g002
https://figshare.com/articles/figure/Results_of_the_survival_curve_fit_the_Sorafenib_of_the_base-case_analysis_in_the_partitioned_survival_model_/25336831

المؤلفون: Qiuping Chen, Quan Sun, Jing Zhang, Baixue Li, Quansheng Feng, Jibin Liu

مصطلحات موضوعية: Medicine, Ecology, Cancer, Science Policy, Biological Sciences not elsewhere classified, main factors affecting, economic advantage grew, current economic conditions, brought health benefits, access database (<, way sensitivity analysis, probabilistic sensitivity analysis, within 1000 times, unresectable hepatocellular carcinoma, patients ’ lifetime, monte carlo simulation, sorafenib therapeutic scheme, tislelizumab vs sorafenib, tislelizumab therapeutic scheme, wtp &# 8805, tislelizumab group generated, tislelizumab group became, psa results showed, pd ), cost, oswa results showed, effectiveness acceptability curves, china ($ 37653, sorafenib group, tislelizumab group

Relation: https://figshare.com/articles/figure/Incremental_cost-effectiveness_scatter_plot_/25336837

الاتاحة: https://doi.org/10.1371/journal.pone.0295090.g004
https://figshare.com/articles/figure/Incremental_cost-effectiveness_scatter_plot_/25336837

المؤلفون: Qiuping Chen, Quan Sun, Jing Zhang, Baixue Li, Quansheng Feng, Jibin Liu

مصطلحات موضوعية: Medicine, Ecology, Cancer, Science Policy, Biological Sciences not elsewhere classified, main factors affecting, economic advantage grew, current economic conditions, brought health benefits, access database (<, way sensitivity analysis, probabilistic sensitivity analysis, within 1000 times, unresectable hepatocellular carcinoma, patients ’ lifetime, monte carlo simulation, sorafenib therapeutic scheme, tislelizumab vs sorafenib, tislelizumab therapeutic scheme, wtp &# 8805, tislelizumab group generated, tislelizumab group became, psa results showed, pd ), cost, oswa results showed, effectiveness acceptability curves, china ($ 37653, sorafenib group, tislelizumab group

Relation: https://figshare.com/articles/figure/Cost-effectiveness_acceptability_curve_/25336840

الاتاحة: https://doi.org/10.1371/journal.pone.0295090.g005
https://figshare.com/articles/figure/Cost-effectiveness_acceptability_curve_/25336840

المؤلفون: Qiuping Chen, Quan Sun, Jing Zhang, Baixue Li, Quansheng Feng, Jibin Liu

مصطلحات موضوعية: Medicine, Ecology, Cancer, Science Policy, Biological Sciences not elsewhere classified, main factors affecting, economic advantage grew, current economic conditions, brought health benefits, access database (<, way sensitivity analysis, probabilistic sensitivity analysis, within 1000 times, unresectable hepatocellular carcinoma, patients ’ lifetime, monte carlo simulation, sorafenib therapeutic scheme, tislelizumab vs sorafenib, tislelizumab therapeutic scheme, wtp &# 8805, tislelizumab group generated, tislelizumab group became, psa results showed, pd ), cost, oswa results showed, effectiveness acceptability curves, china ($ 37653, sorafenib group, tislelizumab group

Relation: https://figshare.com/articles/dataset/Base-case_analysis_results_/25336846

الاتاحة: https://doi.org/10.1371/journal.pone.0295090.t002
https://figshare.com/articles/dataset/Base-case_analysis_results_/25336846

المؤلفون: Qiuping Chen, Quan Sun, Jing Zhang, Baixue Li, Quansheng Feng, Jibin Liu

مصطلحات موضوعية: Medicine, Ecology, Cancer, Science Policy, Biological Sciences not elsewhere classified, main factors affecting, economic advantage grew, current economic conditions, brought health benefits, access database (<, way sensitivity analysis, probabilistic sensitivity analysis, within 1000 times, unresectable hepatocellular carcinoma, patients ’ lifetime, monte carlo simulation, sorafenib therapeutic scheme, tislelizumab vs sorafenib, tislelizumab therapeutic scheme, wtp &# 8805, tislelizumab group generated, tislelizumab group became, psa results showed, pd ), cost, oswa results showed, effectiveness acceptability curves, china ($ 37653, sorafenib group, tislelizumab group

Relation: https://figshare.com/articles/dataset/Model_parameters_Baseline_values_ranges_and_distributions_for_sensitivity_analysis_/25336843

الاتاحة: https://doi.org/10.1371/journal.pone.0295090.t001
https://figshare.com/articles/dataset/Model_parameters_Baseline_values_ranges_and_distributions_for_sensitivity_analysis_/25336843

المؤلفون: Qiuping Chen, Quan Sun, Jing Zhang, Baixue Li, Quansheng Feng, Jibin Liu

مصطلحات موضوعية: Medicine, Ecology, Cancer, Science Policy, Biological Sciences not elsewhere classified, main factors affecting, economic advantage grew, current economic conditions, brought health benefits, access database (<, way sensitivity analysis, probabilistic sensitivity analysis, within 1000 times, unresectable hepatocellular carcinoma, patients ’ lifetime, monte carlo simulation, sorafenib therapeutic scheme, tislelizumab vs sorafenib, tislelizumab therapeutic scheme, wtp &# 8805, tislelizumab group generated, tislelizumab group became, psa results showed, pd ), cost, oswa results showed, effectiveness acceptability curves, china ($ 37653, sorafenib group, tislelizumab group

Relation: https://figshare.com/articles/figure/The_one-way_sensitivity_analysis_results_presented_by_tornado_diagram_/25336834

الاتاحة: https://doi.org/10.1371/journal.pone.0295090.g003

المؤلفون: Qiuping Chen, Quan Sun, Jing Zhang, Baixue Li, Quansheng Feng, Jibin Liu

مصطلحات موضوعية: Medicine, Ecology, Cancer, Science Policy, Biological Sciences not elsewhere classified, main factors affecting, economic advantage grew, current economic conditions, brought health benefits, access database (<, way sensitivity analysis, probabilistic sensitivity analysis, within 1000 times, unresectable hepatocellular carcinoma, patients ’ lifetime, monte carlo simulation, sorafenib therapeutic scheme, tislelizumab vs sorafenib, tislelizumab therapeutic scheme, wtp &# 8805, tislelizumab group generated, tislelizumab group became, psa results showed, pd ), cost, oswa results showed, effectiveness acceptability curves, china ($ 37653, sorafenib group, tislelizumab group

Relation: https://figshare.com/articles/figure/Incremental_cost-effectiveness_scatter_plot_/25336837

الاتاحة: https://doi.org/10.1371/journal.pone.0295090.g004

المؤلفون: Qiuping Chen, Quan Sun, Jing Zhang, Baixue Li, Quansheng Feng, Jibin Liu

مصطلحات موضوعية: Medicine, Ecology, Cancer, Science Policy, Biological Sciences not elsewhere classified, main factors affecting, economic advantage grew, current economic conditions, brought health benefits, access database (<, way sensitivity analysis, probabilistic sensitivity analysis, within 1000 times, unresectable hepatocellular carcinoma, patients ’ lifetime, monte carlo simulation, sorafenib therapeutic scheme, tislelizumab vs sorafenib, tislelizumab therapeutic scheme, wtp &# 8805, tislelizumab group generated, tislelizumab group became, psa results showed, pd ), cost, oswa results showed, effectiveness acceptability curves, china ($ 37653, sorafenib group, tislelizumab group

Relation: https://figshare.com/articles/dataset/Model_parameters_Baseline_values_ranges_and_distributions_for_sensitivity_analysis_/25336843

الاتاحة: https://doi.org/10.1371/journal.pone.0295090.t001

المؤلفون: Qiuping Chen, Quan Sun, Jing Zhang, Baixue Li, Quansheng Feng, Jibin Liu

مصطلحات موضوعية: Medicine, Ecology, Cancer, Science Policy, Biological Sciences not elsewhere classified, main factors affecting, economic advantage grew, current economic conditions, brought health benefits, access database (<, way sensitivity analysis, probabilistic sensitivity analysis, within 1000 times, unresectable hepatocellular carcinoma, patients ’ lifetime, monte carlo simulation, sorafenib therapeutic scheme, tislelizumab vs sorafenib, tislelizumab therapeutic scheme, wtp &# 8805, tislelizumab group generated, tislelizumab group became, psa results showed, pd ), cost, oswa results showed, effectiveness acceptability curves, china ($ 37653, sorafenib group, tislelizumab group

Relation: https://figshare.com/articles/dataset/Base-case_analysis_results_/25336846

الاتاحة: https://doi.org/10.1371/journal.pone.0295090.t002